Advertisement

Why TG Therapeutics Is Plunging More Than 40% Today

Why TG Therapeutics Is Plunging More Than 40% Today

Investors are rattled by the FDA's request for an out-of-the-ordinary meeting dedicated to scrutinizing the company's latest drug approval request.